A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluation

David E. Gerber; Gary L. Gallia; Betty M. Tyler; Charles G. Eberhart; Gar Royer; Stuart A. Grossman

doi:10.1002/jbm.a.33207

A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluation

David E. Gerber, Gary L. Gallia, Betty M. Tyler, Charles G. Eberhart, Gar Royer, Stuart A. Grossman

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

The treatment of intracranial malignancies is limited by the ability of systemically administered therapies to cross the blood-brain barrier. Royer resorbable matrix, or R-Gel, is a dextran polymer administered in liquid form via needle injection. Within minutes of preparation, the polymer forms a gel and subsequently solidifies, thereby conforming to the dimensions of the injection cavity. R-Gel can accommodate a wide variety of therapeutic agents that may provide new options for local treatment delivery. This preclinical study evaluates the neurotoxicity of R-Gel implanted in the rat brain. Fifteen rats underwent intracranial administration of R-Gel (N = 9) or saline (N = 6) were monitored for systemic and neurotoxicity, and sacrificed at pre-determined time points. Animals that received the R-Gel injection demonstrated no behavioral changes or weight loss. Histopathologic analysis revealed an inflammatory response in both groups on day 3 and day 7 after implantation, which resolved by day 42. These results suggest that intracranial R-Gel is well tolerated. Therapeutic studies of chemotherapy-complexed R-Gel are underway.

Original language	English (US)
Pages (from-to)	479-484
Number of pages	6
Journal	Journal of Biomedical Materials Research - Part A
Volume	99 A
Issue number	3
DOIs	https://doi.org/10.1002/jbm.a.33207
State	Published - Dec 1 2011

Keywords

brain tumor
glioma
interstitial chemotherapy
local therapy
polymer

ASJC Scopus subject areas

Ceramics and Composites
Biomaterials
Biomedical Engineering
Metals and Alloys

Access to Document

10.1002/jbm.a.33207

Fingerprint Dive into the research topics of 'A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluation'. Together they form a unique fingerprint.

Cite this

A novel polymer gel for the delivery of local therapies to intracranial tumors : In vivo safety evaluation. / Gerber, David E.; Gallia, Gary L.; Tyler, Betty M.; Eberhart, Charles G.; Royer, Gar; Grossman, Stuart A.

In: Journal of Biomedical Materials Research - Part A, Vol. 99 A, No. 3, 01.12.2011, p. 479-484.

Research output: Contribution to journal › Article › peer-review

@article{aafc79c96ef041e4b0f1a29d3c02112c,

title = "A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluation",

abstract = "The treatment of intracranial malignancies is limited by the ability of systemically administered therapies to cross the blood-brain barrier. Royer resorbable matrix, or R-Gel, is a dextran polymer administered in liquid form via needle injection. Within minutes of preparation, the polymer forms a gel and subsequently solidifies, thereby conforming to the dimensions of the injection cavity. R-Gel can accommodate a wide variety of therapeutic agents that may provide new options for local treatment delivery. This preclinical study evaluates the neurotoxicity of R-Gel implanted in the rat brain. Fifteen rats underwent intracranial administration of R-Gel (N = 9) or saline (N = 6) were monitored for systemic and neurotoxicity, and sacrificed at pre-determined time points. Animals that received the R-Gel injection demonstrated no behavioral changes or weight loss. Histopathologic analysis revealed an inflammatory response in both groups on day 3 and day 7 after implantation, which resolved by day 42. These results suggest that intracranial R-Gel is well tolerated. Therapeutic studies of chemotherapy-complexed R-Gel are underway.",

keywords = "brain tumor, glioma, interstitial chemotherapy, local therapy, polymer",

author = "Gerber, {David E.} and Gallia, {Gary L.} and Tyler, {Betty M.} and Eberhart, {Charles G.} and Gar Royer and Grossman, {Stuart A.}",

year = "2011",

month = dec,

day = "1",

doi = "10.1002/jbm.a.33207",

language = "English (US)",

volume = "99 A",

pages = "479--484",

journal = "Journal of Biomedical Materials Research - Part A",

issn = "0021-9304",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - A novel polymer gel for the delivery of local therapies to intracranial tumors

T2 - In vivo safety evaluation

AU - Gerber, David E.

AU - Gallia, Gary L.

AU - Tyler, Betty M.

AU - Eberhart, Charles G.

AU - Royer, Gar

AU - Grossman, Stuart A.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The treatment of intracranial malignancies is limited by the ability of systemically administered therapies to cross the blood-brain barrier. Royer resorbable matrix, or R-Gel, is a dextran polymer administered in liquid form via needle injection. Within minutes of preparation, the polymer forms a gel and subsequently solidifies, thereby conforming to the dimensions of the injection cavity. R-Gel can accommodate a wide variety of therapeutic agents that may provide new options for local treatment delivery. This preclinical study evaluates the neurotoxicity of R-Gel implanted in the rat brain. Fifteen rats underwent intracranial administration of R-Gel (N = 9) or saline (N = 6) were monitored for systemic and neurotoxicity, and sacrificed at pre-determined time points. Animals that received the R-Gel injection demonstrated no behavioral changes or weight loss. Histopathologic analysis revealed an inflammatory response in both groups on day 3 and day 7 after implantation, which resolved by day 42. These results suggest that intracranial R-Gel is well tolerated. Therapeutic studies of chemotherapy-complexed R-Gel are underway.

AB - The treatment of intracranial malignancies is limited by the ability of systemically administered therapies to cross the blood-brain barrier. Royer resorbable matrix, or R-Gel, is a dextran polymer administered in liquid form via needle injection. Within minutes of preparation, the polymer forms a gel and subsequently solidifies, thereby conforming to the dimensions of the injection cavity. R-Gel can accommodate a wide variety of therapeutic agents that may provide new options for local treatment delivery. This preclinical study evaluates the neurotoxicity of R-Gel implanted in the rat brain. Fifteen rats underwent intracranial administration of R-Gel (N = 9) or saline (N = 6) were monitored for systemic and neurotoxicity, and sacrificed at pre-determined time points. Animals that received the R-Gel injection demonstrated no behavioral changes or weight loss. Histopathologic analysis revealed an inflammatory response in both groups on day 3 and day 7 after implantation, which resolved by day 42. These results suggest that intracranial R-Gel is well tolerated. Therapeutic studies of chemotherapy-complexed R-Gel are underway.

KW - brain tumor

KW - glioma

KW - interstitial chemotherapy

KW - local therapy

KW - polymer

UR - http://www.scopus.com/inward/record.url?scp=80054997144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054997144&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.33207

DO - 10.1002/jbm.a.33207

M3 - Article

C2 - 21887743

AN - SCOPUS:80054997144

VL - 99 A

SP - 479

EP - 484

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 0021-9304

IS - 3

ER -